A female pattern of ischemic heart disease--a new look at an old problem

Agnieszka Janion-Sadowska1, Marcin Sadowski, Marianna Janion

  • 1Swietokrzyskie Cardiology Center, Provincial Polyclinical Hospital, Kielce. mjanion@interia.pl

Przeglad Lekarski
|July 10, 2012
PubMed

Insights

Cardiovascular diseases are a leading cause of death in women and often underestimated. Research suggests a distinct "female pattern" of ischemic heart disease requires comprehensive risk assessment and aggressive management.

Area of Science:

  • Cardiology
  • Women's Health
  • Internal Medicine

Background:

  • Cardiovascular diseases are the leading cause of mortality in women, yet often underestimated in clinical practice.
  • Women present differently than men with ischemic heart disease, often lacking significant coronary angiography stenosis.
  • The prognosis for women with ischemic heart disease is serious, necessitating a re-evaluation of risk assessment and management.

Purpose of the Study:

  • To highlight the underestimation of cardiovascular diseases in women.
  • To discuss the characteristics of the "female pattern" of ischemic heart disease.
  • To emphasize the importance of comprehensive risk assessment and management strategies for women.

Main Methods:

  • Review of existing literature and studies on ischemic heart disease in women.
  • Analysis of diagnostic parameters including noninvasive tests, inflammation indicators, endothelial dysfunction, and microvascular reactivity.
  • Evaluation of treatment benefits from risk factor modification and standard pharmacotherapy.

Main Results:

  • Women with ischemic heart disease exhibit a pattern of atypical chest pain, positive noninvasive tests, and non-significant coronary angiography findings.
  • Global risk assessment in women should incorporate inflammation, endothelial dysfunction, and microvascular reactivity.
  • Intensive risk factor modification and standard pharmacotherapy (ACE inhibitors, beta-blockers, statins) show potential benefits.

Conclusions:

  • Ischemic heart disease in women requires a distinct diagnostic and management approach, recognizing the "female pattern".
  • Comprehensive assessment of global risk factors is crucial for accurate diagnosis and prognosis.
  • Aggressive management focusing on risk factor elimination and evidence-based pharmacotherapy is recommended.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...